Dr. Lerman's Renovascular Disease Lab at Mayo Clinic studies the development of metabolic syndrome and potential new treatment options.

Contact the Renovascular Disease Lab at Mayo Clinic about clinical studies or research on renovascular disease, cardiorenal interactions and microcirculation.

Dr. Lerman's Renovascular Disease Lab at Mayo Clinic studies use of functional MRI and other imaging to assess renal and cardiac hemodynamics and renal fibrosis.

The Lerman Renovascular Disease Lab at Mayo Clinic is developing new diagnostic techniques and therapies for cardiovascular disease.

Learn more about services at Mayo Clinic.Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional ...

The Nucleic Acid Structure and Recognition Lab at Mayo Clinic studies DNA flexibility, novel DNA-RNA-based drug therapies and rare cancers.

The Lung Cancer Research Program at Mayo Clinic studies genomic and environmental factors that impact the development and prognosis of lung cancer in never smokers.

Services The Microscopy and Cell Analysis Core provides three complimentary high-end services to research and clinical investigators. Electron microscopy The core has both scanning electron ...

Improving lung cancer survival Our program is driving the discovery of genetic causes of lung cancer. Our ultimate goal with this lung cancer research is improving early detection and helping lung ...

Equipment and Facilities Major instrumentation Electron microscopy Transmitted electron microscopes, scanning electron microscopes and a serial blockface electron microscope. Flow cytometry and cell ...

The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic offers access to the Mayo PKD Clinical Database to study autosomal dominant polycystic kidney disease (ADPKD).

The CT Clinical Innovation Center at Mayo Clinic develops and evaluates new computerized tomography (CT) technology, clinical applications and dose-reduction techniques.